Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer

Sawada, Masashi; Kasuga, Akiyoshi; Mie, Takafumi; Furukawa, Takaaki; Taniguchi, Takanobu; Fukuda, Koshiro; Yamada, Yuto; Takeda, Tsuyoshi; Kanata, Ryo; Matsuyama, Masato; Sasaki, Takashi; Ozaka, Masato; Sasahira, Naoki

doi:10.1186/s12885-020-06945-8

BMC Cancer

Article metrics
Last updated: Fri, 19 Apr 2024 1:09:49 Z

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer

Access & Citations

6426

Article Accesses
28

Web of Science
39

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com